Remdesivir is an antiviral drug currently being studied as a potential treatment of pneumonia caused by infection with SARS-CoV-2. The Adaptive Covid-19 Treatment Trial (ACTT-1) by NIH and the SIMPLE study by Gilead Sciences are two major trials that showed promising results of Remdesivir in the non-pregnant population. We are presenting the case of a pregnant patient who was diagnosed with COVID-19 pneumonia and successfully treated with Remdesivir.

Spontaneous pneumomediastinum (SPM), a rare occurrence, is defined by the presence of extraluminal gas in the mediastinum in the absence of trauma or underlying parenchymal disease. It is usually benign and has been associated with the inhalation of marijuana, cocaine, and amphetamines. The breathing maneuvers along with cyclical vomiting have been postulated as the underlying etiology. We present a case of a 27-year-old previously healthy male who presented with sudden onset chest pain and was found to have marijuana-induced pneumomediastinum.

Pulmonary embolism and deep vein thrombosis are a major cause of hospitalization and cause high mortality. Several risk factors, such as smoking, immobilization, cancer, trauma, OCPs, pregnancy, and surgery, have already been identified. The diagnosis of PE can sometimes rely on high clinical suspicion. We report a case of a young 31-year-old male with no known risk factors, who developed a PE after 5 months of clomiphene therapy.

Lyme disease is a tick-borne illness that occurs in stages, multiple organs and tissue with highly variable clinical presentation. Most commonly, it presents with seventh cranial nerve palsy, often mimicking stroke and atypical rash (erythema migrans). Atypical presentations include abdominal pain, ileus/pseudo-obstruction and constipation thought to be due to autonomic dysfunction. Other less common presentations include Syndrome of Inappropriate Antidiuretic Hormones (SIADH). Lyme disease should be a differential when a patient presents from Lyme endemic areas with abdominal pain, constipation and SIADH in the setting of other causes of gastrointestinal and renal symptoms ruled out. Here we present a case of multisystem involvement in a single patient with Lyme Disease along with neuroborreliosis (neurological manifestation of Lyme disease).

<p class="abstract"><strong>Background: </strong>The objective of the study was to evaluate the impact of vibratory stimulation on the orthodontic tooth movement rate in growing patients and to compare the orthodontic tooth movement rate in experimental and control sides.</p><p class="abstract"><strong>Methods: </strong>Split-mouth design study was done on 30 growing fixed appliance therapy orthodontic cases with bilateral first premolar extractions in maxillary arch. Individual canine retractions were performed in all the subjects with type-1 active tiebacks. Oral-B powered toothbrushes (125 Hz) were used to provide vibratory stimulation for 15 minutes per day (splits into 5 minutes thrice a day). The tooth movement was measured with calibrated digital vernier caliper clinically at various time intervals (T0, T1 and T2). OPG were taken at regular mentioned time intervals and grid method was used to calculate the tooth movement on OPGs.</p><p class="abstract"><strong>Results:</strong> Results were evaluated statistically and the p-value revealed significantly increased rate of tooth movement on experimental side as compared to control side.</p><p class="abstract"><strong>Conclusions: </strong>The high-frequency vibratory stimulation along with fixed orthodontic appliance can reduce treatment time expeditiously in growing patients. Powered toothbrushes can use successfully for providing vibrations to enhance the rate of tooth movement.</p>